18F-氟雌二醇PET/CT正确诊断雌激素受体阳性乳腺癌患者18F-FDG高摄取炎性淋巴结
一例77岁女性左侧乳腺癌患者初诊分期时行18F-FDG PET/CT,见双侧腋窝FDG高摄取淋巴结;因原发灶雌激素受体(ER)阳性,患者进一步行18F-氟雌二醇(F-FES)PET/CT,淋巴结未见明显F-FES摄取,最终将淋巴结FDG摄取判读为炎症。作者认为F-FES PET可无创评估ER状态,或有助于揭示ER阳性乳腺癌患者FDG PET中假阳性病灶的病理性质。
要点
- ER阳性乳腺癌患者FDG高摄取淋巴结需鉴别转移与炎症
- F-FES PET/CT淋巴结无摄取,支持炎性而非转移
- F-FES PET或可无创揭示FDG假阳性病灶性质
核心结论
- 作者认为F-FES PET可无创评估ER状态,或有助于揭示ER阳性乳腺癌患者FDG PET中假阳性病灶的病理性质。
研究设计与样本
- 一例77岁女性左侧乳腺癌患者的病例报告,初诊分期行18F-FDG PET/CT,因原发灶ER阳性进一步行18F-FES PET/CT。
主要发现
- 18F-FDG PET/CT见双侧腋窝FDG高摄取淋巴结。
- 18F-FES PET/CT示淋巴结未见明显F-FES摄取,与原发灶不同。
- 淋巴结FDG摄取最终判读为炎症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 77-year-old woman with left breast cancer received F-FDG PET/CT for initial staging, and F-FDG-avid lymph nodes were observed in the bilateral axillae. As estrogen receptor (ER) status of primary lesion was positive, the patient also received F-fluoroestradiol (F-FES) PET/CT. Unlike primary lesion, no remarkable F-FES uptakes in the lymph nodes were observed. F-FDG uptakes in the nodes were finally interpreted as inflammation. F-FES PET that can noninvasively evaluate the ER status may have a potential to reveal the pathology of the false-positive lesion observed in F-FDG PET for patients with ER-positive breast cancer.
引用
- Yamane T, Ueda S, Seto A, et al. 18F-Fluoroestradiol PET/CT Correctly Diagnosed 18F-FDG-Avid Inflammatory Lymph Nodes in a Patient With Estrogen Receptor-Positive Breast Cancer. Clin Nucl Med. 2018. PMID: 29485433. doi:10.1097/RLU.0000000000002041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。